Initial Project Information: MACRO
Home European R&D List
ITHACA Mansev
Updated: Jun 3, 97  

MACRO

Multimedia application for clinical research in oncology

[ Coordinator(s) ] [ Participants ] [ Project Objectives, ... ] [ Other Characteristics ]

Project Nr: HC 1030 Group: II Project Duration: 36 months
Key words:
Category:European Clinical Research Network
Summary: Creates a secure, user friendly, reliable and affordable clinical trials system for oncology.
Mission:MACRO will demonstrate a unified European network for remote entry of data into clinical research trials. It will provide an efficient means of two-way communication between the central office co-ordinating a trial and the hospital clinicians who treats the patients. The MACRO solution will enhance the speed and quality of the clinical trials and should help attract more research to Europe. The work from previous EU projects and from other current projects will be integrated into a common telematics infrastructure for health care. The system to be demonstrated by MACRO in the field of cancer is expected to extend to other branches of medicine. MACRO participates in the project cluster entitled: ACTION for Telematics Applications for Cooperative work of Healthcare Professionals.
URL: www.eortc.be/macro

Coordinator(s)

  • Mr. Gordon J. McVie
    Cancer Research Campaign
    Cambridge Terrace, 6-10
    UK-NW1 4JL London
    United Kingdom
    tel: 44 17 12 24 13 33
    fax: 44 17 14 87 43 02
    stm@eortc.be
    url:

Participants:

Name of InstitutionCity+Postal CodeCountryRegion
Integral Solutions Limited Basingstoke RG21 4RG United Kingdom UK56
Padcom Clinical Research Bonn D-53121 Germany DEA2

Project Objectives, Summary Description and Anticipated Results

The MACRO project develops a demonstrator of the telematics-based interaction between parties in clinical research:
  • clinical trial offices which co-ordinate studies at regional, national, and European level
  • clinicians in the hospitals, who treat the patients and provide clinical information to the clinical trials office.

The project aims at:

  • the creation of a European network for Clinical Research for facilitating the international co-operation in clinical trials
  • and the demonstration on that network of an integrated system based on clinical databases, remote data entry, study monitoring, and patient randomisation software, in order to assess the impact of telematics on data quality and on the speed of the clinical research process, as well as the administrative ease of participating in clinical research.

The approach is to integrate in a common telematics infrastructure commercial products and results achieved by previous research projects, e.g. EuroCODE and MARIA. The integration work will be performed by an industrial partner following the requirements of Health Care professionals. Oncology has been selected as the initial model. The demonstrator will compare several solutions based on MS-Windows front-ends and World Wide Web technology.

The use of telematics techniques such as Remote Data Entry and Remote Study Monitoring will facilitate the participation in clinical trials and therefore increase the enrolment of patients and accelerate the introduction of more advanced treatment strategies. Once effectively demonstrated, the MACRO Application will be commercialised for use by any interested parties in the Medical Community at large, this will include other specialised agencies such as that for AIDS research as well as those individual physicians who have the facility of hooking into this application, and the Pharmaceutical Industry.

Other Characteristics of the Project:

Users involved
  • Clinical trial offices: data managers, statisticians, medical supervisors.
  • Hospitals: clinicians, local data managers.
    Technologies and/or approach used
  • Technologies: World Wide Web and technologies created in former European projects, e.g. Dilemma.
  • Approach: Integration of existing products in a common telematics infrastructure.
    Expected benefits for the citizen
  • Faster proof making and availability of more efficient treatment modalities.
  • Reduction of mortality and morbidity in Europe.
    Expected benefits for the users of the application
  • Decrease of workload of participating in clinical trials.
  • Facilitated participation in clinical research.
    Expected benefits for the European Industries
  • Increase of the cost-effectiveness of clinical research in Europe.
  • Advanced software and standards for research activities.
  • Clear and consistent telematics infrastructure.
    Contribution to EU-policies
  • Reduction of mortality and morbidity in Europe.
  • Support of research activities on a European wide scale in Pharmaceutical Industry.
  • Validation Sites

    EORTC Data Centre Brussels Bruxelles Cap. BE
    UZ KUL Gasthuisberg Leuven Vlaams-Brabant BE
    Antoni Van Leeuwenhoekhuis Amsterdam Noord-Holland NL
    Daniel Den Hoed Kliniek,University Hospital Rotterdam N Zuid-Holland NL
    Institut Gustave Roussy Villejuif Ile de France FR
    Centre Georges-François Leclerc Dijon Bourgogne FR
    Rigshospitalet Copenhagen Koebenhavn OG, Frederiksberg Kom. DK
    Centre Léon Bérard Lyon Rhône-Alpes FR
    Aarhus University Hospital Aarhus Aarhus AMT DK

    [ Top ] [ Coordinator(s) ] [ Participants ] [ Project Objectives, ... ] [ Other Characteristics ]

    ITHACA Mansev Next
    Back to the Main Page
    Copyright 1997 © EHTO All rights reserved
    This server is the only official EHTO WWW knowledge repository.
    Mail suggestions to: webmaster@ehto.org